The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways
Abstract
The Cbfa1/Runx2 is an important transcription factor necessary for osteoblast differentiation and bone formation. However, the signaling pathways regulating Runx2 activity are just beginning to be understood. Inconsistencies between Runx2 mRNA or protein levels and its transcriptional activity suggests that posttranslational modification and/or protein‐protein interactions may regulate this factor. Runx2 can be phosphorylated and activated by the mitogen‐activated protein kinase (MAPK) pathway. This pathway can be stimulated by a variety of signals including those initiated by extracellular matrix (ECM), osteogenic growth factors like bone morphogenic proteins (BMPs) and fibroblast growth factor‐2 (FGF‐2), mechanical loading and hormones such as parathyroid hormone (PTH). Protein kinase A (PKA) may also phosphorylate/activate Runx2 under certain conditions. In addition, Runx2 activity is enhanced by protein‐protein interactions as are seen with PTH‐induced Runx2/AP‐1 and BMP‐mediated Runx2/Smads interactions. Mechanisms for interaction with Runx2 are complex including binding of distinct components such as AP‐1 factors and Smads proteins to separate DNA regions in target gene promoters and direct physical interactions between Runx2 and AP‐1/Smad factors. Post‐translational modifications such as phosphorylation may influence interactions between Runx2 and other nuclear factors. These findings suggest that Runx2 plays a central role in coordinating multiple signals involved in osteoblast differentiation. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W. H., Beddington, R. S. P., Mundlos, S., Olsen, B. R., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80259-7 · Cited by 2,814
Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia
Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll, J. H. M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80260-3 · Cited by 1,522
The Osteoblast: A Sophisticated Fibroblast under Central Surveillance
Ducy, P., Schinke, T., & Karsenty, G. (2000) · Science · doi:10.1126/science.289.5484.1501 · Cited by 1,120
Lee, K.-S., Kim, H.-J., Li, Q.-L., Chi, X.-Z., Ueta, C., Komori, T., Wozney, J. M., Kim, E.-G., Choi, J.-Y., Ryoo, H.-M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8783-8792.2000 · Cited by 865
Maturational disturbance of chondrocytes inCbfa1-deficient mice
Inada, M., Yasui, T., Nomura, S., Miyake, S., Deguchi, K., Himeno, M., Sato, M., Yamagiwa, H., Kimura, T., Yasui, N., et al. (1999) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199904)214:4<279::aid-aja1>3.0.co;2-w · Cited by 570
MAPK Pathways Activate and Phosphorylate the Osteoblast-specific Transcription Factor, Cbfa1
Xiao, G., Jiang, D., Thomas, P., Benson, M. D., Guan, K., Karsenty, G., & Franceschi, R. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4453 · Cited by 552
Self-citationNugent, M. A., & Iozzo, R. V. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00123-5 · Cited by 547
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation
Montero, A., Okada, Y., Tomita, M., Ito, M., Tsurukami, H., Nakamura, T., Doetschman, T., Coffin, J. D., & Hurley, M. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8641 · Cited by 483 · cited 1×
“Overexpression of FGF-2 in transgenic mice causes premature mineralization, achondroplasia and shortening of long bones while disruption of the FGF-2 gene leads to decreased bone mass and bone formation [Coffin et al., 1995; Montero et al., 2000].”
Background
Cited by
Bone Tissue Engineering: State of the Art and Future Trends
Salgado, A. J., Coutinho, O. P., & Reis, R. L. (2004) · Macromolecular Bioscience · doi:10.1002/mabi.200400026 · Cited by 1,681
Wu, M., Chen, G., & Li, Y.-P. (2016) · Bone Research · doi:10.1038/boneres.2016.9 · Cited by 1,553
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Johnson, R. C., Leopold, J. A., & Loscalzo, J. (2006) · Circulation Research · doi:10.1161/01.res.0000249379.55535.21 · Cited by 944
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Langenbach, F., & Handschel, J. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt328 · Cited by 662
A complete immunoglobulin gene is created by somatic recombination
Brack, C., Hirama, M., Lenhard-Schuller, R., & Tonegawa, S. (1978) · Cell · doi:10.1016/0092-8674(78)90078-8 · Cited by 610
Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB
Bai, X.-C., Lu, D., Bai, J., Zheng, H., Ke, Z.-Y., Li, X.-M., & Luo, S.-Q. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.073 · Cited by 561
Vascular Calcification: The Killer of Patients with Chronic Kidney Disease
Mizobuchi, M., Towler, D., & Slatopolsky, E. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070692 · Cited by 542
Stein, G. S., Lian, J. B., Wijnen, A. J. V., Stein, J. L., Montecino, M., Javed, A., Zaidi, S. K., Young, D. W., Choi, J.-Y., & Pockwinse, S. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207676 · Cited by 538
Networks and hubs for the transcriptional control of osteoblastogenesis
Lian, J. B., Stein, G. S., Javed, A., van Wijnen, A. J., Stein, J. L., Montecino, M., Hassan, M. Q., Gaur, T., Lengner, C. J., & Young, D. W. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9001-5 · Cited by 468
The runx genes: gain or loss of function in cancer
Blyth, K., Cameron, E. R., & Neil, J. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1607 · Cited by 455
Salasznyk, R. M., Williams, W. A., Boskey, A., Batorsky, A., & Plopper, G. E. (2004) · BioMed Research International · doi:10.1155/s1110724304306017 · Cited by 417
Specification and connectivity of neuronal subtypes in the sensory lineage
Marmigère, F., & Ernfors, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2057 · Cited by 415
Pathogenesis of myeloma bone disease
Roodman, G. D. (2009) · Leukemia · doi:10.1038/leu.2008.336 · Cited by 398
Luo, X.-H., Guo, L.-J., Xie, H., Yuan, L.-Q., Wu, X.-P., Zhou, H.-D., & Liao, E.-Y. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060707 · Cited by 369
Yamashita, M., Ying, S.-X., Zhang, G.-M., Li, C., Cheng, S. Y., Deng, C.-X., & Zhang, Y. E. (2005) · Cell · doi:10.1016/j.cell.2005.01.035 · Cited by 355
Giuliani, N., Colla, S., Morandi, F., Lazzaretti, M., Sala, R., Bonomini, S., Grano, M., Colucci, S., Svaldi, M., & Rizzoli, V. (2005) · Blood · doi:10.1182/blood-2004-12-4986 · Cited by 325
Ghrelin Directly Regulates Bone Formation
Fukushima, N., Hanada, R., Teranishi, H., Fukue, Y., Tachibana, T., Ishikawa, H., Takeda, S., Takeuchi, Y., Fukumoto, S., Kangawa, K., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041237 · Cited by 319
Salasznyk, R. M., Klees, R. F., Williams, W. A., Boskey, A., & Plopper, G. E. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.09.013 · Cited by 305
Multiple myeloma bone disease: pathophysiology of osteoblast inhibition
Giuliani, N., Rizzoli, V., & Roodman, G. D. (2006) · Blood · doi:10.1182/blood-2006-05-026112 · Cited by 302
Pathogenesis of myeloma bone disease
Roodman, G. D. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22403 · Cited by 296
Tseng, P.-C., Hou, S.-M., Chen, R.-J., Peng, H.-W., Hsieh, C.-F., Kuo, M.-L., & Yen, M.-L. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.460 · Cited by 291
Hamidouche, Z., Fromigué, O., Ringe, J., Häupl, T., Vaudin, P., Pagès, J.-C., Srouji, S., Livne, E., & Marie, P. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812334106 · Cited by 290
Murphy, C. M., Matsiko, A., Haugh, M. G., Gleeson, J. P., & O’Brien, F. J. (2012) · Journal of the Mechanical Behavior of Biomedical Materials · doi:10.1016/j.jmbbm.2011.11.009 · Cited by 262
Xiao, Z., Zhang, S., Mahlios, J., Zhou, G., Magenheimer, B. S., Guo, D., Dallas, S. L., Maser, R., Calvet, J. P., Bonewald, L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604772200 · Cited by 254
Prospective Review of Mesenchymal Stem Cells Differentiation into Osteoblasts
Garg, P., Mazur, M. M., Buck, A. C., Wandtke, M. E., Liu, J., & Ebraheim, N. A. (2017) · Orthopaedic Surgery · doi:10.1111/os.12304 · Cited by 190
Jun, J. H., Yoon, W.-J., Seo, S.-B., Woo, K.-M., Kim, G.-S., Ryoo, H.-M., & Baek, J.-H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142307 · Cited by 167
Rucci, N., Rufo, A., Alamanou, M., & Teti, A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21059 · Cited by 108
The osteoblastic niche in the context of multiple myeloma
Toscani, D., Bolzoni, M., Accardi, F., Aversa, F., & Giuliani, N. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12578 · Cited by 52
MiR-30 family: a novel avenue for treating bone and joint diseases?
Huang, J., Li, Y., Zhu, S., Wang, L., Yang, L., & He, C. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.81990 · Cited by 23
Metadata
- Authors
- Franceschi, R. T., & Xiao, G.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2003-01-16
- Volume
- 88
- Issue
- 3
- Pages
- 446-454
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1967402039
- Cited by
- 541
- References
- 40
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.